399 related articles for article (PubMed ID: 19368956)
21. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
Engellau J; Bendahl PO; Persson A; Domanski HA; Akerman M; Gustafson P; Alvegård TA; Nilbert M; Rydholm A
Hum Pathol; 2005 Sep; 36(9):994-1002. PubMed ID: 16153463
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of macrophage infiltration in leiomyosarcomas.
Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
[TBL] [Abstract][Full Text] [Related]
23. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases.
Kilpatrick SE; Doyon J; Choong PF; Sim FH; Nascimento AG
Cancer; 1996 Apr; 77(8):1450-8. PubMed ID: 8608528
[TBL] [Abstract][Full Text] [Related]
24. [Pathological type of liposarcoma and its effects of clinical treatment].
Fang Z; Li J; Yan H
Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):204-6. PubMed ID: 10374536
[TBL] [Abstract][Full Text] [Related]
25. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
26. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.
Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J
Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434
[TBL] [Abstract][Full Text] [Related]
27. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
28. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity.
Willems SM; van Remoortere A; van Zeijl R; Deelder AM; McDonnell LA; Hogendoorn PC
J Pathol; 2010 Dec; 222(4):400-9. PubMed ID: 20839361
[TBL] [Abstract][Full Text] [Related]
29. Myxoid liposarcoma of the ankle.
Werd MB; DeFronzo DJ; Landsman AS; Surprenant M; Sakoff M
J Foot Ankle Surg; 1995; 34(5):465-74. PubMed ID: 8590881
[TBL] [Abstract][Full Text] [Related]
30. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis.
Knight JC; Renwick PJ; Dal Cin P; Van den Berghe H; Fletcher CD
Cancer Res; 1995 Jan; 55(1):24-7. PubMed ID: 7805034
[TBL] [Abstract][Full Text] [Related]
31. Myxoid liposarcoma of the ankle: a case report.
Nishio J; Isayama T; Yoshimura I; Ohjimi H; Iwasaki H; Naito M
J Foot Ankle Surg; 2012; 51(1):76-9. PubMed ID: 22018762
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
[TBL] [Abstract][Full Text] [Related]
33. Myxoid liposarcoma with cartilaginous differentiation: A case study with fish analysis and review of the literature.
Ioannou MG; Kouvaras E; Papamichali R; Karachalios T; Koukoulis G
Pathol Res Pract; 2013 Oct; 209(10):666-9. PubMed ID: 23920321
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas.
Olofsson A; Willén H; Göransson M; Engström K; Meis-Kindblom JM; Stenman G; Kindblom LG; Aman P
Int J Oncol; 2004 Nov; 25(5):1349-55. PubMed ID: 15492825
[TBL] [Abstract][Full Text] [Related]
35. Re: Oda et al. Frequent alteration of p16INK4a/p14ARF and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14ARF expression both correlate with poor prognosis. J Pathol 2005;207:410-421.
Perrone F; Tamborini E; Suardi S; Lagonigro MS; Pilotti S
J Pathol; 2006 Jun; 209(2):281; author reply 282. PubMed ID: 16622896
[No Abstract] [Full Text] [Related]
36. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract][Full Text] [Related]
37. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.
Martinez V; Kennedy S; Doolan P; Gammell P; Joyce H; Kenny E; Prakash Mehta J; Ryan E; O'Connor R; Crown J; Clynes M; O'Driscoll L
Breast Cancer Res Treat; 2008 Aug; 110(3):521-30. PubMed ID: 17899366
[TBL] [Abstract][Full Text] [Related]
38. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors.
Matsumine A; Shintani K; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Iino T; Uchida A
J Surg Oncol; 2007 Oct; 96(5):411-8. PubMed ID: 17579351
[TBL] [Abstract][Full Text] [Related]
39. Neurological deficit from metastatic low grade liposarcoma.
Taweevisit M; Thanakit V
J Med Assoc Thai; 2005 Apr; 88(4):538-40. PubMed ID: 16146262
[TBL] [Abstract][Full Text] [Related]
40. Gene expression in mixed type liposarcoma.
Kim JI; Choi KU; Lee IS; Moon TY; Lee CH; Kim HW; Kim JY; Park DY; Sol MY
Pathology; 2006 Apr; 38(2):114-9. PubMed ID: 16581650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
